Alnylam Pharmaceuticals
ALNY
#541
Rank
ยฃ32.82 B
Marketcap
ยฃ248.46
Share price
0.31%
Change (1 day)
11.24%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company